Anavex Life Sciences
AVXL
#7478
Rank
โ‚น36.14 B
Marketcap
โ‚น390.05
Share price
-1.41%
Change (1 day)
-51.61%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚น4.03 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น4.79 Billion a decrease over its 2023 earnings that were of -โ‚น4.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น4.03 Billion-15.85%
2024 -โ‚น4.79 Billion14.77%
2023 -โ‚น4.18 Billion-17.49%
2022 -โ‚น5.06 Billion22.96%
2021 -โ‚น4.12 Billion35.36%
2020 -โ‚น3.04 Billion12.65%
2019 -โ‚น2.7 Billion29.09%
2018 -โ‚น2.09 Billion36.33%
2017 -โ‚น1.54 Billion17.11%
2016 -โ‚น1.31 Billion20.91%
2015 -โ‚น1.09 Billion-6.29%
2014 -โ‚น1.16 Billion337.28%
2013 -โ‚น0.27 Billion
2008 -โ‚น0.49 Billion106.01%
2007 -โ‚น0.24 Billion8848.98%
2006 -โ‚น2.65 Million-79.99%
2005 -โ‚น13.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น6.20 B-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น6.08 B-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.45 Billion-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น0.62 Billion-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA